Peptidylglycine α-amidating monooxygenase heterozygosity alters brain copper handling with region specificity

Journal of Neurochemistry

Volumn 127, Issue 5, 2013, Pages 605-619

  Gaier, Eric D ^a   Miller, Megan B ^a   Ralle, Martina ^b   Aryal, Dipendra ^c   Wetsel, William C ^c   Mains, Richard E ^a   Eipper, Betty A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

amygdala; Atp7a; dopamine monooxygenase; neuropeptide; PSD; subcellular fractionation

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ALPHA AMIDATING ENZYME; CARRIER PROTEINS AND BINDING PROTEINS; COPPER; MENKES PROTEIN; MESSENGER RNA; PROTEIN ATOX 1; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL FRACTIONATION; CONTROLLED STUDY; COPPER DEFICIENCY; EMBRYO; FEMALE; GENE EXPRESSION; GENE FUNCTION; HETEROZYGOSITY; IMMUNOHISTOCHEMISTRY; INTERNEURON; MALE; MOUSE; NONHUMAN; PAM GENE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SYNAPTOSOME;

MAMMALIA; MUS;

AMYGDALA; ATP7A; DOPAMINE Β-MONOOXYGENASE; NEUROPEPTIDE; PSD; SUBCELLULAR FRACTIONATION;

ADENOSINE TRIPHOSPHATASES; AMYGDALA; ANIMALS; CATECHOLAMINES; CATION TRANSPORT PROTEINS; CELLS, CULTURED; CEREBRAL CORTEX; COPPER; FEMALE; HETEROZYGOTE; HIPPOCAMPUS; INTERNEURONS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MIXED FUNCTION OXYGENASES; MULTIENZYME COMPLEXES; PREGNANCY; SUBCELLULAR FRACTIONS; TRANS-GOLGI NETWORK;

EID: 84887617438     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12438     Document Type: Article

References (54)

1. Anderson D. W., Bradbury K. A., and, Schneider J. S., (2008) Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism. Eur. J. Neurosci. 28, 610-617.
2. Andreini C., Banci L., Bertini I., and, Rosato A., (2008) Occurrence of copper proteins through the three domains of life: a bioinformatic approach. J. Proteome Res. 7, 209-216.
3. de Bie P., Muller P., Wijmenga C., and, Klomp L. W., (2007) Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes. J. Med. Genet. 44, 673-688.
4. Bousquet-Moore D., Mains R. E., and, Eipper B. A., (2010a) Peptidylgycine alpha-amidating monooxygenase and copper: a gene-nutrient interaction critical to nervous system function. J. Neurosci. Res. 88, 2535-2545.
5. Bousquet-Moore D., Prohaska J. R., Nillni E. A., Czyzyk T., Wetsel W. C., Mains R. E., and, Eipper B. A., (2010b) Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction. Neurobiol. Dis. 37, 130-140.
6. Carlin R. K., Grab D. J., Cohen R. S., and, Siekevitz P., (1980) Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities. J. Cell Biol. 86, 831-845.
7. Chuang C. Y., Shi Y. C., You H. P., Lo Y. H., and, Pan T. M., (2011) Antidepressant effect of GABA-rich monascus-fermented product on forced swimming rat model. J. Agric. Food Chem. 59, 3027-3034.
8. De Vries D. J., Sewell R. B., and, Beart P. M., (1986) Effects of copper on dopaminergic function in the rat corpus striatum. Exp. Neurol. 91, 546-558.
9. De M., Ciccotosto G. D., Mains R. E., and, Eipper B. A., (2007) Trafficking of a secretory granule membrane protein is sensitive to copper. J. Biol. Chem. 282, 23362-23371.
10. Donsante A., Sullivan P., Goldstein D. S., Brinster L. R., and, Kaler S. G., (2013) L-threo-dihydroxyphenylserine corrects neurochemical abnormalities in a Menkes disease mouse model. Ann. Neurol. 73, 259-265.
11. Doreulee N., Yanovsky Y., and, Haas H. L., (1997) Suppression of long-term potentiation in hippocampal slices by copper. Hippocampus 7, 666-669.
12. El Meskini R., Culotta V. C., Mains R. E., and, Eipper B. A., (2003) Supplying copper to the cuproenzyme peptidylglycine alpha-amidating monooxygenase. J. Biol. Chem. 278, 12278-12284.
13. Francone V. P., Ifrim M. F., Rajagopal C., Leddy C. J., Wang Y., Carson J. H., Mains R. E., and, Eipper B. A., (2010) Signaling from the secretory granule to the nucleus: Uhmk1 and PAM. Mol. Endocrinol. 24, 1543-1558.
14. Gaier E. D., Rodriguiz R. M., Ma X. M., Sivaramakrishnan S., Bousquet-Moore D., Wetsel W. C., Eipper B. A., and, Mains R. E., (2010) Haploinsufficiency in peptidylglycine alpha-amidating monooxygenase leads to altered synaptic transmission in the amygdala and impaired emotional responses. J. Neurosci. 30, 13656-13669.
15. Gaier E. D., Eipper B. A., and, Mains R. E., (2013) Copper signaling in the mammalian nervous system: synaptic effects. J. Neurosci. Res. 91, 2-19.
16. Goldstein D. S., Holmes C. S., and, Kaler S. G., (2009) Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease. Neurochem. Res. 34, 1464-1468.
17. Greenough M., Pase L., Voskoboinik I., Petris M. J., O'Brien A. W., and, Camakaris J., (2004) Signals regulating trafficking of Menkes (MNK; ATP7A) copper-translocating P-type ATPase in polarized MDCK cells. Am. J. Physiol. Cell Physiol. 287, C1463-C1471.
18. Hamza I., Faisst A., Prohaska J., Chen J., Gruss P., and, Gitlin J. D., (2001) The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proc. Natl Acad. Sci. USA 98, 6848-6852.
19. Hansel D. E., May V., Eipper B. A., and, Ronnett G. V., (2001) Pituitary adenylyl cyclase-activating peptides and alpha-amidation in olfactory neurogenesis and neuronal survival in vitro. J. Neurosci. 21, 4625-4636.
20. Huttner W. B., Schiebler W., Greengard P., and, De C. P., (1983) Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J. Cell Biol. 96, 1374-1388.
21. Itoh S., Kim H. W., Nakagawa O., Ozumi K., Lessner S. M., Aoki H., Akram K., McKinney R. D., Ushio-Fukai M., and, Fukai T., (2008) Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation. J. Biol. Chem. 283, 9157-9167.
22. Kaler S. G., (2011) ATP7A-related copper transport diseases-emerging concepts and future trends. Nat. Rev. Neurol. 7, 15-29.
23. Kardos J., Samu J., Ujszaszi K., Nagy J., Kovacs I., Visy J., Maksay G., and, Simonyi M., (1984) Cu2 + is the active principle of an endogenous substance from porcine cerebral cortex which antagonizes the anticonvulsant effect of diazepam. Neurosci. Lett. 52, 67-72.
24. Kardos J., Kovacs I., Hajos F., Kalman M., and, Simonyi M., (1989) Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitability. Neurosci. Lett. 103, 139-144.
25. Ke B. X., Llanos R. M., Wright M., Deal Y., and, Mercer J. F., (2006) Alteration of copper physiology in mice overexpressing the human Menkes protein ATP7A. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R1460-R1467.
26. Klinman J. P., (2006) The copper-enzyme family of dopamine beta-monooxygenase and peptidylglycine alpha-hydroxylating monooxygenase: resolving the chemical pathway for substrate hydroxylation. J. Biol. Chem. 281, 3013-3016.
27. La Fontaine S., and, Mercer J. F., (2007) Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch. Biochem. Biophys. 463, 149-167.
28. Leiva J., Gaete P., and, Palestini M., (2003) Copper interaction on the long-term potentiation. Arch. Ital. Biol. 141, 149-155.
29. Lin C. J., Huang H. C., and, Jiang Z. F., (2010) Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains. Brain Res. Bull. 82, 235-242.
30. Linz R., and, Lutsenko S., (2007) Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins. J. Bioenerg. Biomembr. 39, 403-407.
31. Lutsenko S., (2010) Human copper homeostasis: a network of interconnected pathways. Curr. Opin. Chem. Biol. 14, 211-217.
32. Lutsenko S., Barnes N. L., Bartee M. Y., and, Dmitriev O. Y., (2007) Function and regulation of human copper-transporting ATPases. Physiol. Rev. 87, 1011-1046.
33. Ma X. M., Johnson R. C., Mains R. E., and, Eipper B. A., (2001) Expression of kalirin, a neuronal GDP/GTP exchange factor of the trio family, in the central nervous system of the adult rat. J. Comp. Neurol. 429, 388-402.
34. Ma X. M., Mains R. E., and, Eipper B. A., (2002) Plasticity in hippocampal peptidergic systems induced by repeated electroconvulsive shock. Neuropsychopharmacology 27, 55-71.
35. Ma X. M., Kiraly D. D., Gaier E. D., Wang Y., Kim E. J., Levine E. S., Eipper B. A., and, Mains R. E., (2008) Kalirin-7 is required for synaptic structure and function. J. Neurosci. 28, 12368-12382.
36. Mains R. E., Milgram S. L., Keutmann H. T., and, Eipper B. A., (1995) The NH2-terminal proregion of peptidylglycine alpha-amidating monooxygenase facilitates the secretion of soluble proteins. Mol. Endocrinol. 9, 3-13.
37. Mains R. E., Kiraly D. D., Eipper-Mains J. E., Ma X. M., and, Eipper B. A., (2011) Kalrn promoter usage and isoform expression respond to chronic cocaine exposure. BMC Neurosci. 12, 20.
38. Maltese J.-Y., and, Eipper B. A., (1992) Developmental expression of peptidylglycine alpha-amidating monooxygenase (PAM) in primary cultures of neonatal rat cardiocytes: a model for studying regulation of PAM expression in the rat heart. Mol. Endocrinol. 6, 1998-2008.
39. Mathie A., Sutton G. L., Clarke C. E., and, Veale E. L., (2006) Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability. Pharmacol. Ther. 111, 567-583.
40. McDonald A. J., and, Mascagni F., (2004) Parvalbumin-containing interneurons in the basolateral amygdala express high levels of the alpha1 subunit of the GABAA receptor. J. Comp. Neurol. 473, 137-146.
41. McDonald A. J., Mascagni F., and, Muller J. F., (2004) Immunocytochemical localization of GABABR1 receptor subunits in the basolateral amygdala. Brain Res. 1018, 147-158.
42. Mefford I. N., Kincl L., Dykstra K. H., Simpson J. T., Markey S. P., Dietz S., and, Wightman R. M., (1996) Facile oxidative decarboxylation of 3,4-dihydroxyphenylacetic acid catalyzed by copper and manganese ions. Biochim. Biophys. Acta 1290, 224-230.
43. Nakamura N., Rabouille C., Watson R., Nilsson T., Hui N., Slusarewicz P., Kreis T. E., and, Warren G., (1995) Characterization of a cis-Golgi matrix protein, GM130. J. Cell Biol. 131, 1715-1726.
44. Niciu M. J., Ma X. M., El Meskini R., Ronnett G. V., Mains R. E., and, Eipper B. A., (2006) Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment. Neuroscience 139, 947-964.
45. Niciu M. J., Ma X. M., El Meskini R., Pachter J. S., Mains R. E., and, Eipper B. A., (2007) Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease. Neurobiol. Dis. 27, 278-291.
46. Petris M. J., Mercer J. F., Culvenor J. G., Lockhart P., Gleeson P. A., and, Camakaris J., (1996) Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J. 15, 6084-6095.
47. Prigge S. T., Mains R. E., Eipper B. A., and, Amzel L. M., (2000) New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell. Mol. Life Sci. 57, 1236-1259.
48. Rajagopal C., Stone K. L., Francone V. P., Mains R. E., and, Eipper B. A., (2009) Secretory granule to the nucleus: role of a multiply phosphorylated intrinsically unstructured domain. J. Biol. Chem. 284, 25723-25734.
49. Rush R. A., and, Geffen L. B., (1980) Dopamine beta-hydroxylase in health and disease. Crit. Rev. Clin. Lab. Sci. 12, 241-277.
50. Schlief M. L., Craig A. M., and, Gitlin J. D., (2005) NMDA receptor activation mediates copper homeostasis in hippocampal neurons. J. Neurosci. 25, 239-246.
51. Schlief M. L., West T., Craig A. M., Holtzman D. M., and, Gitlin J. D., (2006) Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity. Proc. Natl Acad. Sci. USA 103, 14919-14924.
52. Steveson T. C., Ciccotosto G. D., Ma X. M., Mueller G. P., Mains R. E., and, Eipper B. A., (2003) Menkes protein contributes to the function of peptidylglycine alpha-hydroxylating monooxygenase. Endocrinology 144, 188-200.
53. Uriu-Adams J. Y., and, Keen C. L., (2005) Copper, oxidative stress, and human health. Mol. Aspects Med. 26, 268-298.
54. Zomosa-Signoret V., Arnaud J. D., Fontes P., varez-Martinez M. T., and, Liautard J. P., (2008) Physiological role of the cellular prion protein. Vet. Res. 39, 9.